Global Optical Preclinical Imaging Devices Market Overview:
Preclinical imaging is the design of live animals for research purposes such as drug development. Imaging techniques were essential for the researchers to observe changes at the organ, tissue, cell, or molecular level in animals that respond to physiological or environmental changes. Imaging modalities that are not aggressive and have become particularly important to examine animal models in the longitudinal direction. These imaging systems can be divided into mainly morphological/anatomical and mainly molecular imaging techniques. Techniques such as high-frequency micro-ultrasound, magnetic resonance imaging (MRI), and computed tomography (CT) are commonly used for anatomical imaging, while optical imaging (fluorescence and bioluminescence), positron emission tomography (PET) and single-photon emission are calculated. Tomography (SPECT) is usually used for molecular visualizations used.
- Increasing Geriatric Population across the globe and Growing
- Highly Demanded Due To Accurate Results
- Development of Healthcare Infrastructure due to Increasing Healthcare Expenditure
- Growing Use Of Artificial Intelligence In Medical Imaging
- Demand In Augmented Reality And Virtual Reality Are New Emerging Applications
- High Risk of Weighing the Radiation
- Increasing Government and Private Medical Bodies Initiative for Developing Health Care Infrastructure
- Highly Demanded Due To Different Life-Threatening Disease Requires Quick Diagnostic Results
- Lack of Awareness about Optical Preclinical Imaging Devices among People
- Lack of Medical Infrastructure in Many Geographical Regions
The companies are now exploring the market by adopting mergers & acquisitions, expansions, investments, new developments in existing products, and collaborations as their preferred strategies. The players are also exploring new geographies and industries through expansions and acquisitions so as to avail a competitive advantage through combined synergies.
Some of the key players profiled in the report are ThermoFisher Scientific (United States), Bruker Corporation (United States), Perkin Elmer (United States), MR Solutions (United Kingdom), BioTek Instruments (United States), Milabs (Netherlands), FUJIFILM Visualsonics, Inc. (Canada), Magnetic Insight Inc. (United States), MBF Bioscience (United States), Mediso (Budapest), LI-COR Biosciences (United States), Aspect Imaging (Israel), TriFoil Imaging (United States) and Miltenyi Biotech GmbH (Germany). Analyst at AdvanceMarketAnalytics see United States Players to retain maximum share of Global Optical Preclinical Imaging Devices market by 2025. Considering Market by Reagents Types, the sub-segment i.e. Bioluminescent Imaging Reagents will boost the Optical Preclinical Imaging Devices market. Considering Market by Distribution Channel, the sub-segment i.e. Online will boost the Optical Preclinical Imaging Devices market.
In December 2019 Fujifilm to Acquire Hitachi’s Diagnostic Imaging-related Business to Accelerate Growth of Its Healthcare Business. FUJIFILM Corporation announced that it has agreed with Hitachi, Ltd. to acquire Hitachi’s Diagnostic Imaging-related Business to further expand its Healthcare business. Fujifilm will acquire all the outstanding shares of the New Company from Hitachi. The completion of this acquisition is subject to customary closing conditions and regulatory approvals.
The Atomic Energy (Radiation Protection) Rules, 2004 [AE(RP)R-2004], promulgated under the Atomic Energy Act, 1962, provides the legal framework for the safe handling of radiation generating equipment. As per Rule 3 of AE(RP)R-2004 it is mandatory for all the manufacturers/Suppliers/Users of x-ray equipment, to obtain requisite ‘Licence’ from AERB for carrying out any kind of activity.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be provided prior to purchase
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Optical Preclinical Imaging Devices market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Optical Preclinical Imaging Devices market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Providers of Optical Preclinical Imaging Devices, End-Users, Potential Investors, Market Research Firms, Regulatory Bodies and Others.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.